海南海药：预计2025年净亏损3.5亿元—4.3亿元

Core Viewpoint - Hainan Haiyao expects a net loss of 350 million to 430 million yuan in 2025 due to intensified market competition and various policy impacts [1] Group 1: Financial Outlook - The company anticipates a net loss ranging from 350 million to 430 million yuan for the year 2025 [1] - Increased depreciation expenses are expected as raw material projects transition to fixed assets [1] - High interest expenses are anticipated due to a large scale of interest-bearing liabilities, which will further impact the company's performance [1] Group 2: Market and Policy Environment - The competitive landscape is expected to intensify due to the influence of medical insurance and centralized procurement policies [1] - The company's innovative drugs have not yet been launched, and newly listed generic drugs have not gained significant market volume [1]